SIX Swiss Exchange · Healthcare
Invest in Aevis Victoria stock from India
Indian and foreign residents can buy Aevis Victoria (AEVS) shares directly through Paasa.
By Paasa · Updated
Aevis Victoria at a glance
- Price
- CHF 15.75-CHF 0.05 (0.32%)
- Market cap
- CHF 1.33B
- Day range
- CHF 15.60 – CHF 15.85
- P/E
- -69.78
- Dividend yield
- None
- Volume
- 3.99K
- 1 month
- +22.57%
- 6 months
- +19.77%
- YTD
- +17.98%
- 1 year
- +21.15%
- 5 years
- +21.15%
Aevis Victoria statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 1.1B | CHF 1.0B | CHF 914.4M | CHF 1.0B | CHF 823.3M |
| Gross profit | CHF 193.0M | CHF 789.9M | CHF 170.1M | CHF 185.4M | CHF 137.6M |
| Operating income | −CHF 51.1M | −CHF 24.4M | −CHF 37.6M | −CHF 27.4M | −CHF 45.0M |
| Net income | −CHF 20.1M | −CHF 2.9M | −CHF 39.3M | CHF 58.8M | −CHF 4.3M |
| Earnings per share | −CHF 0.24 | −CHF 0.03 | −CHF 0.47 | CHF 0.70 | −CHF 0.05 |
| EBITDA | CHF 24.9M | CHF 92.5M | CHF 49.1M | CHF 128.3M | CHF 83.5M |
| Total assets | CHF 1.9B | CHF 2.0B | CHF 1.9B | CHF 1.8B | CHF 1.7B |
| Total debt | CHF 949.8M | CHF 1.1B | CHF 1.0B | CHF 970.0M | CHF 841.3M |
| Cash and short-term investments | CHF 29.0M | CHF 36.9M | CHF 80.7M | CHF 75.4M | CHF 63.4M |
| Shareholders' equity | CHF 509.8M | CHF 530.9M | CHF 491.9M | CHF 469.3M | CHF 485.9M |
| Operating cash flow | CHF 72.6M | CHF 46.5M | CHF 42.7M | CHF 114.3M | CHF 33.5M |
| Free cash flow | CHF 4.9M | −CHF 18.8M | −CHF 66.1M | CHF 40.3M | −CHF 24.1M |
| Capital expenditure | −CHF 67.7M | −CHF 65.3M | −CHF 108.7M | −CHF 74.0M | −CHF 57.6M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Tecan | TECN.SW | CHF 234.40 | CHF 2.97B |
| SKAN | SKAN.SW | CHF 70.70 | CHF 1.59B |
| PolyPeptide | PPGN.SW | CHF 44.10 | CHF 1.46B |
| Idorsia | IDIA.SW | CHF 4.65 | CHF 1.22B |
| Medartis | MED.SW | CHF 84.00 | CHF 1.05B |
| Cosmo Pharmaceuticals | COPN.SW | CHF 58.70 | CHF 1.01B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Aevis Victoria from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search AEVS and buy
Find Aevis Victoria by name or by its ticker, AEVS, and place your order.
Why invest in Aevis Victoria from India
What Aevis Victoria does
Aevis Victoria SA is a Swiss holding company with diversified interests spanning the healthcare, hospitality, lifestyle, and infrastructure sectors. Its operational structure is divided into key segments: Hospitals, Hospitality, Telemedicine, and Real Estate. Aevis Victoria operates in the Medical - Care Facilities industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Aevis Victoria stock from India?
Yes. Indian residents and NRIs can buy Aevis Victoria (AEVS) shares directly through Paasa. Aevis Victoria is listed on the SIX Swiss Exchange, in the Medical - Care Facilities industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Aevis Victoria shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.